Literature DB >> 10825128

Monoallelic amplification of estrogen receptor-alpha expression in breast cancer.

E R Schuur1, R J Weigel.   

Abstract

Gene amplification and loss of heterozygosity are alterations to chromosomal structure whereby tumor cells alter patterns of gene expression. We have identified a novel mechanism of gene regulation in which cancer cells predominantly express one of the two alleles of a gene. Estrogen receptor (ER)-alpha is overexpressed in hormone-responsive breast cancer compared with normal breast epithelial cells. Using a polymorphism of codon 10, we examined allele-specific expression of the four different ER promoters in MCF-7 breast cancer cells and primary tumors. Monoallelic amplification of expression (MAX) for all four ER promoters was identified, resulting in an allelic preference of > 100-fold. MAX was the result of an amplification of allele copy number and a preference to transcribe the amplified allele. The effect of MAX was most significant for the promoters clustered near the 1' exon, whereas the expression from the distant H promoter mirrored template copy number. MAX of the ER gene was not found to occur in normal endometrial or breast tissue. As a novel mechanism in cancer genetics, MAX can result in functional homozygosity at a gene locus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825128

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry.

Authors:  Anne-Vibeke Laenkholm; Ann Knoop; Bent Ejlertsen; Tine Rudbeck; Maj-Britt Jensen; Sven Müller; Anne Elisabeth Lykkesfeldt; Birgitte Bruun Rasmussen; Kirsten Vang Nielsen
Journal:  Mol Oncol       Date:  2012-05-08       Impact factor: 6.603

Review 2.  Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate.

Authors:  Frederik Holst
Journal:  World J Clin Oncol       Date:  2016-04-10

3.  Potential therapeutic benefit of combining gefitinib and tamoxifen for treating advanced lung adenocarcinoma.

Authors:  Chien-Ming Liu; Kuo-Liang Chiu; Tzu-Sheng Chen; Shang-Miao Chang; Shu-Yun Yang; Li-Hsiou Chen; Yung-Lun Ni; Yuh-Pyng Sher; Sung-Liang Yu; Wen-Lung Ma
Journal:  Biomed Res Int       Date:  2015-01-26       Impact factor: 3.411

4.  Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours.

Authors:  Liesel M FitzGerald; Kelsie Raspin; James R Marthick; Matt A Field; Roslyn C Malley; Russell J Thomson; Nicholas B Blackburn; Annette Banks; Jac C Charlesworth; Shaun Donovan; Joanne L Dickinson
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

5.  Introns control stochastic allele expression bias.

Authors:  Bryan Sands; Soo Yun; Alexander R Mendenhall
Journal:  Nat Commun       Date:  2021-11-11       Impact factor: 17.694

Review 6.  Amping up estrogen receptors in breast cancer.

Authors:  Amy M Fowler; Elaine T Alarid
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

7.  Breast cancer mammospheres secrete Adrenomedullin to induce lipolysis and browning of adjacent adipocytes.

Authors:  Martin Paré; Cédric Y Darini; Xi Yao; Bérengère Chignon-Sicard; Samah Rekima; Simon Lachambre; Virginie Virolle; Adriana Aguilar-Mahecha; Mark Basik; Christian Dani; Annie Ladoux
Journal:  BMC Cancer       Date:  2020-08-20       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.